Armen Shanafelt Net Worth & Insider Trades
Armen Shanafelt - Director, Aeglea Biotherapeutics, Inc
What is Armen Shanafelt's Net Worth?
The current estimated net worth of Aeglea Biotherapeutics, Inc's Director, Armen Shanafelt, is estimated to be about $33.94M . Armen Shanafelt owns about 150,000 units of Aeglea Biotherapeutics, Inc common stock. In the last 6 years at Aeglea Biotherapeutics, Inc, Armen Shanafelt has sold an estimated value of $0 worth.
What is Armen Shanafelt's Past Insider Trading?
Armen Shanafelt's largest purchase order was 150,000 units , worth over $549.69K on December 13, 2021. In total, Armen Shanafelt has made about 8 transactions over 6 years of their time at Aeglea Biotherapeutics, Inc. Armen Shanafelt usually trades in June, with the busiest year in 2021.
Armen Shanafelt
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Armen Shanafelt's' Mailing Address?
- Mailing address is C/o Lilly Ventures Fund I, Llc 115 W. Washington Street,ste 1680-South Indianapolis IN 46204 IN
Aeglea Biotherapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Anthony G. Quinn, M.B Ch.B, Ph.D. | 2020 | $538,000 | $2,089,861 | $2,089,861 | $25,745 | $2,909,606 |
| Anthony G. Quinn, M.B Ch.B, Ph.D. | 2019 | $518,000 | $1,663,919 | $1,663,919 | $53,857 | $2,482,776 |
| Charles N. York II | 2020 | $415,000 | $860,415 | $860,415 | $8,053 | $1,283,468 |
| Charles N. York II | 2019 | $390,000 | $522,424 | $522,424 | $7,712 | $1,085,136 |
| Leslie Sloan, Ph.D. | 2020 | $370,000 | $707,970 | $707,970 | $20,349 | $1,246,319 |
| Leslie Sloan, Ph.D. | 2019 | $355,000 | $632,380 | $632,380 | $19,843 | $1,149,223 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1636282/000156459021019953/agle-def14a_20210608.htm
What are Aeglea Biotherapeutics, Inc's Past Insider Trades?
Aeglea Biotherapeutics, Inc's most recent insider trade came on August 25, 2022 by Marcio Souza who bought 90,000 units worth $50.47K . In the last 6 years, insiders at Aeglea Biotherapeutics, Inc have sold an estimated value of $1.43M and bought an estimated value of $13.71M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Anthony Quinn, President & CEO, Armen Shanafelt, Director, and Charles N. York II, Chief Financial Officer and VP .
Aeglea BioTherapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||